Article thumbnail

Induction chemotherapy with paclitaxel, ifosfamide, and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancer

By I Chitapanarux, E Tharavichitkul, V Lorvidhaya, P Sittitrai and T Pattarasakulchai
Topics: Case Report
Publisher: Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Malaysia
OAI identifier: oai:pubmedcentral.nih.gov:3097775
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data.
  2. (2004). Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: evolution of the sequential treatment approach. Semin Oncol.
  3. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.
  4. (1996). Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group.
  5. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
  6. (1998). Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.
  7. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
  8. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo.
  9. (2006). Randomized phase III trial comparing induction chemotherapy using cisplatin fluorouracil with or without docetaxel for organ preservation in hypopharynx and larynx cancer. Proc Am Soc Clin Oncol.
  10. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma.
  11. Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.